Citron Research's Andrew Left takes aim at cannabis companies after bringing down more than 40 companies in other sectors

In recent months, short-seller Andrew Left, founder of Citron Research, has waged a particularly acrimonious series of attacks against cannabis companies through a series of blistering research reports and Twitter barrages against Cronos Group (NASDAQ:CRON), Tilray Inc (NASDAQ: TLRY) and CV Sciences (OTCMKTS: CVSI) to name a few.

But none has been as noisy as his most recent target, Namaste Technologies (OTCMKTS:NXTTF), which operates the medical cannabis market CannMart as well as an online platform that markets cannabis-related products like vaporizers and smoking accessories in 20 countries and via 30 websites.

In recent weeks, through Citron, he’s called Namaste shares a “joke” and the company a “fraud,” even going so far on Thursday to call its CEO Sean Dollinger a “walking securities violation.”

“If Namaste was a US traded company it would be halted and Dollinger would probably face criminal charges,” wrote Left’s team in a note to investors.

The company has responded to defend itself, but the shares have dipped as a result of Left’s public criticisms, falling 5.3% to $1.64 on Friday.

Last month, Namaste confirmed its plans to uplist to the Nasdaq, citing its jump in sales and increase in share price.

Citron’s no-holds-barred report said the uplisting claim was fake and used for the sole purpose of luring investors into buying the stock, going on to say that the exchange would “laugh Dollinger out of the room given his seedy background and the company’s opaque finances.”

For Left, the dramatic run-up in the shares of marijuana companies ahead of the legalization of cannabis in Canada on October 17 is even more ridiculous, he says, than “bitcoin mania.”

But Left’s ire isn’t limited to the cannabis sector; Here is a list of more than 40 companies that have become targets of US regulatory intervention after being on the receiving end of Left’s criticism:

• Xaibe Inc. (OTCBB: XAIB)
• Humatech Inc OTC Pink: HUMT)
• Tel-One Inc. (OTCBB:TLON)
• eUniverse Inc (NASDAQ:EUNI)
• Concentrax Inc (OTC Pink: CRXN)
• Stratabase (OTCBB:SBSF)
• GeneMax (OTCBB:GMXX)
• RTIN Holdings Inc (OTCBB:RTNH)
• Spear & Jackson Inc (OTCBB:SJCK)
• Interpharm Holdings Inc (NYSE MKT:IPA)
• American Water Star Inc (OTCBB:AMWS)
• Verdisys/Blast Energy Services Inc (OTCBB:VDSYS, OTCBB:BESV)
• Immtech Pharmaceuticals (NYSE MKT:IMM)
• Amerityre Corp (NASDAQ:AMTY)
• World Information Technology (OTCBB:WRLT)
• YP Net (OTCBB:YPNT)
• Concord America Inc (OTC Pink:CNDD)
• Law Enforcement Associates (OTCBB:LENF)
• Telkonet inc (NYSE MKT:TKO)
• Absolute Health and Fitness Inc (OTC Pink: AHFI)
• iMergent Inc (NYSE MKT: IIG, NYSE MKT: EXE)
• Bio-Heal Laboratories (OTC Pink:BHLL)
• Raser Technologies Inc (OTCBB:RSTG, NYSE:RZ)
• Homeland Safety International (OTC Pink: SNFX, OTC Pink:HSFI)
• Global Development and Environmental Resources (NASDAQ:GDVE)
• GTX Global (OTC Pink:GTXC)
• Escala Group (NASDAQ:ESCL)
• Foldera Inc (OTCBB:FDRA)
• Vertrue Inc (NASDAQ:VRTU)
• GHL Technologies (OTC Pink:GHLT)
• Conversion Solutions Holdings Inc (OTCBB:CHSD, OTCBB:FHAL)
• Syntax-Brillian Corp (NASDAQ:BRLC)
• Medis Technologies Ltd (OTC Pink:MDTL)
• Xinhua Finance Media (NASDAQ: XFML)
• Hoku Scientific (NASDAQ:HOKU)
• Home Solutions of America Inc (NASDAQ:HSOA)
• Terra Nostra Resources Corp (OTCBB:TNRO)
• Bidz.Com Inc (NASDAQ:BIDZ)
• Basin Water Inc (NASDAQ:BWTR)
• Arthrocare Corp (NASDAQ:ARTC)
• Ener1.Inc (NASDAQ:HEV)
• Amedisys Inc (NASDAQ:AMED)

Contact Ellen Kelleher at [email protected]

Story by ProactiveInvestors